By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ)

SHZ Currency in CNY
¥5.88
-¥0.02
-0.34%
Last Update: 29 Aug 2025, 07:04
¥3.74B
Market Cap
-13.07
P/E Ratio (TTM)
Forward Dividend Yield
¥4.60 - ¥8.10
52 Week Range

300639.SZ Stock Price Chart

Explore Guangdong Hybribio Biotech Co.,Ltd. interactive price chart. Choose custom timeframes to analyze 300639.SZ price movements and trends.

300639.SZ Company Profile

Discover essential business fundamentals and corporate details for Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

13 Apr 2017

Employees

2.67K

CEO

Jianyu Wang

Description

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.

300639.SZ Financial Timeline

Browse a chronological timeline of Guangdong Hybribio Biotech Co.,Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 29 Apr 2025

EPS came in at -¥0.61 , while revenue for the quarter reached ¥207.08M .

Earnings released on 31 Mar 2025

EPS came in at -¥0.04 , while revenue for the quarter reached ¥134.06M .

Earnings released on 29 Oct 2024

EPS came in at -¥0.29 , while revenue for the quarter reached ¥201.36M .

Earnings released on 28 Aug 2024

EPS came in at -¥0.10 , while revenue for the quarter reached ¥225.78M .

Dividend declared on 23 May 2024

A dividend of ¥0.07 per share was announced, adjusted to ¥0.07. The dividend was paid on 23 May 2024.

Earnings released on 23 Apr 2024

EPS came in at -¥0.02 , while revenue for the quarter reached ¥181.30M .

Earnings released on 23 Feb 2024

EPS came in at -¥0.05 , while revenue for the quarter reached ¥250.18M .

Earnings released on 25 Oct 2023

EPS came in at ¥0.08 , while revenue for the quarter reached ¥243.99M .

Earnings released on 31 Aug 2023

EPS came in at ¥0.09 , while revenue for the quarter reached ¥304.52M .

Dividend declared on 22 May 2023

A dividend of ¥0.53 per share was announced, adjusted to ¥0.35. The dividend was paid on 22 May 2023.

Stock split effective on 22 May 2023

Shares were split 3 : 2 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 24 Apr 2023

EPS came in at ¥0.36 , while revenue for the quarter reached ¥1.34B .

Earnings released on 14 Apr 2023

EPS came in at ¥0.53 , while revenue for the quarter reached ¥302.11M .

Earnings released on 21 Oct 2022

EPS came in at ¥1.17 , while revenue for the quarter reached ¥1.42B .

Earnings released on 15 Aug 2022

EPS came in at ¥1.09 , while revenue for the quarter reached ¥1.33B .

Dividend declared on 29 Apr 2022

A dividend of ¥0.53 per share was announced, adjusted to ¥0.23. The dividend was paid on 29 Apr 2022.

Stock split effective on 29 Apr 2022

Shares were split 3 : 2 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 26 Apr 2022

EPS came in at ¥1.15 , while revenue for the quarter reached ¥1.51B .

Earnings released on 25 Mar 2022

EPS came in at ¥0.47 , while revenue for the quarter reached ¥681.38M .

Earnings released on 19 Oct 2021

EPS came in at ¥0.59 , while revenue for the quarter reached ¥693.01M .

Earnings released on 10 Aug 2021

EPS came in at ¥0.50 , while revenue for the quarter reached ¥689.16M .

Dividend declared on 28 May 2021

A dividend of ¥0.20 per share was announced, adjusted to ¥0.09. The dividend was paid on 28 May 2021.

Stock split effective on 28 May 2021

Shares were split 312853 : 250000 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 19 Apr 2021

EPS came in at ¥0.34 , while revenue for the quarter reached ¥437.68M .

Earnings released on 2 Apr 2021

EPS came in at ¥0.26 , while revenue for the quarter reached ¥609.47M .

Earnings released on 22 Oct 2020

EPS came in at ¥0.36 , while revenue for the quarter reached ¥411.28M .

300639.SZ Stock Performance

Access detailed 300639.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run